OA03.07 KEYNOTE-010: Durable Clinical Benefit in Patients with Previously Treated, PD-L1-Expressing NSCLC Who Completed Pembrolizumab
Roy S. Herbst,Edward B. Garon,Dong-Wan Kim,Byoung Chul Cho,Shirish M. Gadgeel,H. Lena,Alfonso Gurpide,Ji-Youn Han,Catherine Dubos Arvis,Margarita Majem,Martin Forster,Isabelle Monnet,Silvia Novello,Hideo Saka,Zsuzsanna Szalai,Matthew A. Gubens,Wu-Chou Su,Gregory M. Lubiniecki,Yue Shentu,Geri L Ferraro,Paul Baas Journal of Thoracic Oncology（2017）
AI 理解论文
溯源树
样例
